The U.S. Senate Health, Education, Labor, and Pensions (HELP) Committee will hold a hearing on April 16 to discuss ways Congress can reduce the cost of prescription drugs for American families by increasing competition among generic and biosimilar manufacturers. Senator Bill Cassidy, M.D., chairman of the HELP Committee, is leading this initiative as part of President Trump's efforts to make health care more affordable.
The upcoming hearing is titled "Making Medicines More Affordable: How Competition Can Lower Drug Prices" and will take place at 10:00 AM Eastern Time in the Dirksen Senate Office Building. The committee invites members of the press to RSVP if they plan to attend in person.
The HELP Committee plays a significant role in legislating on public health, education, workforce issues and retirement programs with the goal of protecting health and supporting worker rights, according to the official website. In the current session of Congress, Cassidy serves as chair of this committee according to the official website.
As reported by the official website, the committee influences federal regulations affecting health and education across the United States. It also provides oversight of federal laws and agencies in these areas, serving as a key body for policy decisions according to its official website.
Additionally, according to its official website, the committee focuses on federal policy in health, education and labor sectors while overseeing agencies such as the Food and Drug Administration (FDA) and National Institutes of Health (NIH).
Observers say that increased competition among drug manufacturers could lead to lower prices for consumers nationwide. The results from this hearing may shape future legislative efforts aimed at reducing prescription drug costs.
